Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia

Blood

Volumn 89, Issue 8, 1997, Pages 2986-2993

  Findley, Harry W ^a   Gu, Lubing ^a   Yeager, Andrew M ^a   Zhou, Muxiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN P53;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL LINE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; ETIOLOGY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; RADIOSENSITIVITY;

EID: 0030952902     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.2986     Document Type: Article

References (44)

1. Dive C, Hickman JA: Drug-target interactions: Only the first step in the commitment to a programmed cell death? Br J Cancer 64:192, 1991
2. O'Connor PM, Wassermann K, Sarang M, Magrath I, Bohr VA, Kohn KW: Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard. Cancer Res 51:6550, 1991
3. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957, 1993
4. Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell 78:539, 1994
5. Nunez G, London L, Hockenbery D, Alexader M, McKearn JP, Korsmeyer SJ: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602, 1990
6. Chen M, Quintans J, Fuks Z, Thompson C, Kufe DW, Weichselbaum RR: Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor α, and ceramide. Cancer Res 55:991, 1995
7. Alnemri ES, Fernandas TF, Haldar S, Croce CM, Litwack G: Involvement of Bcl-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res 52:491, 1992
8. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151, 1993
9. Chiou SK, Rao L, White E: Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14:2556, 1994
10. Fukunaga-Johnson N, Ryan JJ, Wicha M, Nunez G, Clarke MF: Bcl-2 protects murine erythroleukemia cells from p53-dependent and independent radiation-induced cell death. Carcinogenesis 16:1761, 1995
11. Lotem J, Sachs L: Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and Bcl-2 dependent and independent pathways. Cell Growth Differ 5:321, 1994
12. Reed JC, Kitada S, Takayama S, Miyashita T: Regulation of chemoresistance by the Bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphoblastic leukemia cell lines. Ann Oncol 5:61, 1994
13. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud JP, Guyotat D: High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81:3091, 1993
14. Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G: Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia 9:1191, 1995
15. Gala JL, Vermylen C, Cornu G, Ferrant A, Michaux JL, Philippe M, Martiat P: High expression of Bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis. Ann Hematol 69:17, 1994
16. Coustan-Smith E, Kitanaka A, Pui CH, McNinch L, Evans WE, Raimondi SC, Behm FG, Arico M, Campana D: Clinical relevance of Bcl-2 overexpression in childhood acute lymphoblastic leukemia. Blood 87:1140, 1996
17. Oltvai Z, Milliman C, Korsmeyer S: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609, 1993
18. Yin X, Oltvai Z, Korsmeyer S: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321, 1994
19. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a Bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
20. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ: Bcl-xl and bcl-2 repress a common pathway of cell death. J Exp Med 182:821, 1995
21. Schott AF, Apel IJ, Nunez G, Clarke MF: Bcl-xl protects cancer cells from p53-mediated apoptosis. Oncogene 11:1389, 1995
22. Gottschalk AR, Boise LH, Thompson CB, Quintans J: Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc Natl Acad Sci USA 91:7350, 1994
23. Findley HW, Cooper MD, Kim T, Alvarado C, Ragab A: Two new acute lymphoblastic leukemia cell lines with early pre-B-cell phenotypes. Blood 60:1305, 1982
24. Zhou M, Findley HW, Ma L, Zaki S, Hill T, Hamid M, Hooper W, Ragab A: Effect of tumor necrosis factor-α on the proliferation of leukemic cells from children with B-cell precursor acute lymphoblastic leukemia (BCP-ALL): Studies of primary leukemic cells and BCP-ALL cell lines. Blood 77:2002, 1991
25. Zhou M, Yeager AM, Smith SD, Findley HW: Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood 85:1608, 1995
26. Korsmeyer SJ: bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879, 1992
27. Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Angeletti CA, Basolo F, Bevilacqua G: Bcl-2 protein: A prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer 71:1003, 1995
28. Pezzella F, Turley H, Kuzu I: Bcl-2 protein in non small-cell lung carcinoma. N Engl J Med 329:690, 1993
29. Lepelley P, Soenen V, Preudhomme C, Merlat A, Cosson A, Fenaux P: Bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis. Leukemia 9:726, 1995
30. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T: p53 status and efficacy of cancer therapy in vivo. Science 266:807, 1994
31. Alderson LM, Castleberg RL, Harsh GR, Louis DN, Henson JW: Human gliomas with wild-type p53 express bcl-2. Cancer Res 55:999, 1995
32. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM: Down-regulation of Bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095, 1994
33. Pezzella F, Morrison H, Jones M, Gatter KC, Lane D, Harris AL, Mason DY: Immunohistochemical detection of p53 and Bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 22:39, 1993
34. Yonish-Rouach E, Rensmitzki D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6. Nature 352:345, 1991
35. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed J: Tumor suppressor p53 is a regulator of Bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799, 1994
36. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fornace AJ Jr: Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9:3743, 1994
37. Datta R, Manome Y, Taneja N, Boise LH, Weichselbaum R, Thompson CB, Slapak CA, Kufe D: Overexpression of Bcl-xl by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ 6:363, 1995
38. Dole MG, Jasty R, Cooper MJ, Thompson CB, Nunez G, Castle VP: Bcl-xl is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 55:2576, 1995
39. Park JR, Bernstein ID, Hockenbery D: Primitive human hematopoietic precursors express Bcl-xl but not Bcl-2. Blood 86:868, 1995
40. Gonzalez-Garcia M, Perez-Ballestero R, Ding L, Duan L, Boise L, Thompson C, Nunez G: Bcl-xl is the major Bcl-x mRNA form expressed during murine development and its product is localized to the mitochondria. Development 120:3033, 1994
41. Ma A, Pena J, Chang B, Margosian E, Davidson L, Alt F, Thompson CB: Bcl-xl regulates the surival of double positive thymocytes. Proc Natl Acad Sci USA 92:4763, 1995
42. Lotem J, Sachs L: Regulation of Bcl-2, Bcl-xl and Bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ 6:647, 1995
43. Cheng EH, Levine B, Boise LH, Thompson CB, Hardwick JM: Bax-independent inhibition of apoptosis by Bcl-xl. Nature 379:554, 1996
44. Minn AJ, Rudin CM, Boise LH, Thompson CB: Expression of Bcl-xl can confer a multidrug resistance phenotype. Blood 86:1903, 1995